MEDICO REMEDIES
Back to Cashflow Statement
|
MEDICO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.82 Cr | ₹-5.77 Cr | ₹18 Cr | ₹2.60 Cr | ₹-0.55 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICO REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-1.82 Cr |
Mar2022 | ₹-5.77 Cr |
Mar2021 | ₹18 Cr |
Mar2020 | ₹2.60 Cr |
Mar2019 | ₹-0.55 Cr |
How is Cash Flow from Financing Activities of MEDICO REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1.82 Cr | Negative | |
Mar2022 | ₹-5.77 Cr | Negative | |
Mar2021 | ₹18 Cr | 603.62 | |
Mar2020 | ₹2.60 Cr | Positive | |
Mar2019 | ₹-0.55 Cr | - |
Compare Cash Flow from Financing Activities of peers of MEDICO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICO REMEDIES | ₹315.9 Cr | -4.3% | -19.6% | -54.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹369,570.0 Cr | 0.9% | 1.2% | 63.5% | Stock Analytics | |
CIPLA | ₹119,627.0 Cr | 2.7% | 7.3% | 52% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,316.0 Cr | 9.1% | 18% | 112.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹107,804.0 Cr | 3.2% | 9.5% | 20.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,966.5 Cr | -1.6% | -2.7% | 29.9% | Stock Analytics |
MEDICO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICO REMEDIES | -4.3% |
-19.6% |
-54.7% |
SENSEX | 1.7% |
1.6% |
20.6% |
You may also like the below Video Courses